Ligand Pharmaceuticals, Inc. (LGND)
183.09
-0.94
(-0.51%)
USD |
NASDAQ |
Dec 11, 16:00
183.09
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly): 1.477B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| Inspire Medical Systems, Inc. | 807.72M |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Johnson & Johnson | 192.82B |
| AbbVie, Inc. | 133.90B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 526.60M |
| Shareholders Equity (Quarterly) | 950.17M |
| Debt to Equity Ratio | 0.4746 |
| Current Ratio | 24.69 |
| Net Debt Paydown Yield | -2.55% |